TNF-α is a key proinflammatory factor; several pharmacological studies indicated that TNF-α signaling exacerbates both Aβ peptides and tau protein pathologies in vivo, which are neuropathological hallmarks of AD (Decourt et al., 2017). This evidence concerns the gene MAPT and Alzheimer disease.